CRICKET: Critical Events in Anaesthetised Kids Undergoing Tracheal Intubation
Launched by THOMAS RIVA · Mar 27, 2023
Trial Information
Current as of May 20, 2025
Recruiting
Keywords
ClinConnect Summary
The CRICKET trial is a study looking at how often serious problems happen when children undergo a procedure called tracheal intubation, which is when a tube is placed in the windpipe to help them breathe while they are under general anesthesia. The goal is to gather information from different hospitals around the world to understand the techniques used during intubation and to find ways to make this procedure safer for kids.
This study is open to children aged 0 to 16 who need tracheal intubation as part of their medical treatment. To participate, parents or guardians must provide consent for their child to be involved in the trial. If a child is older than 16 or if consent cannot be given, they will not be eligible to join. Participants in the study will help researchers learn more about the risks involved with intubation, and this information could lead to improvements in how the procedure is performed, ultimately enhancing safety for future patients.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • All paediatric patients requiring tracheal intubation, performed by the anaesthesia team for procedures or interventions requiring general anaesthesia
- • Patients from 0 - 16 years of age.
- • Informed or general consent given, according to the relevant ethics committee statement.
- Exclusion Criteria:
- • Refusal to give consent or withdrawal of consent if such is required by the relevant ethics committee.
- • Patients \>16 years
About Thomas Riva
Thomas Riva is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes. With a focus on innovative therapies and evidence-based practices, the organization collaborates with leading researchers and healthcare institutions to design and conduct rigorous clinical trials. Thomas Riva prioritizes ethical standards and patient safety, ensuring that all studies are conducted in compliance with regulatory guidelines. By fostering partnerships and leveraging cutting-edge technologies, Thomas Riva aims to accelerate the development of groundbreaking treatments that address unmet medical needs.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Boston, Massachusetts, United States
Philadelphia, Pennsylvania, United States
Perth, , Australia
Toronto, Ontario, Canada
Montréal, , Canada
Berlin, , Germany
Genève, , Switzerland
Patients applied
Trial Officials
Robert Greif, MD, Prof
Study Chair
Department of Anaesthesiology and Pain Medicine, Inselspital, Bern University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials